| |
{HtmlEncodeMultiline(EmailPreheader)} | PRICE CONTROLS WITH IMPERFECT COMPETITION AND CHOICE FRICTIONS: EVIDENCE FROM INDIAN PHARMACEUTICALS |
|
|
|
|
| ABSTRACT We study how two common market failures—market power and choice frictions—shape the welfare effects of a large-scale pharmaceutical price control policy in India. The policy reduced the prices of regulated drugs by 24% and increased their sales by 36%, with minimal impact on product entry or exit. A standard revealed-preference welfare analysis suggests substantial gains in consumer and social surplus, as price caps correct monopoly distortions. However, using a survey of physicians’ own drug choices, we show that consumers systematically overvalue regulated products. Incorporating these choice frictions reduces estimated consumer surplus gains by 30% and reveals an overall decline in social welfare. We also evaluate alternative price and non-price regulations that address both market failures. |
Keywords: Price Controls, Imperfect Competition, Product Quality, Pharmaceuticals. JEL: I11, L13, L15, L51, L65. |
Click here to view the CV. Click here to view the paper. |
|
|
PRESENTER Shengmao Cao Northwestern University |
RESEARCH FIELDS Industrial Organization The Economics of Innovation |
DATE: 28 November 2025 (Friday) |
VENUE: Meeting Room 5.1, Level 5 School of Economics Singapore Management University 90 Stamford Road Singapore 178903 |
|
|
|
|
| | © Copyright 2025 by Singapore Management University. All Rights Reserved. Internal recipients of SMU, please visit https://smu.sg/emailrules, on how to filter away this EDM. For all other recipients, please click here to unsubscribe. |
|
|
|
|
|
|
|